Skip to content
HOME discovery services screening efficacy

Tailored iPSC-based assays

Assess compounds’ efficacy with reliable assays and capitalize in the selection of relevant compounds earlier

Get Started

Predictive. Efficient. And designed
for better decisions.

We accomplish your project’s ambitions by developing tailored assays with physiologically relevant human models that allow predictive high-throughput screening of a compound’s efficacy, based on functional and phenotypic changes.

High reproducibility and sensitivity

Consistent models
manufactured at scale

Translational readouts

Evaluate clinically relevant
cellular functions

Confident decision-making

Select compounds with high
probability of clinical success

Ncardia Assays

Our scientific team is highly experienced in developing and optimizing a wide range of custom assays for efficacy evaluation at high-throughput based on the most clinically relevant readouts for your project.

 

Robust efficacy
high-throughput screenings

As more and more drug discovery innovators look to capitalize on the unique value only iPSCs can deliver, they look to Ncardia as the uniquely qualified collaborator to join them on their all-important journeys. We’re ready to help make your next step the very best it can be. So let’s start with a conversation – about your vision, goals and expectations for your drug discovery projects.

Laura, Neuroscientist Screening expert
Laura, screening expert